Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 7,774 | 5,630 | 5,798 | 4,040 | 5,966 |
| Gross Profit | 7,774 | 5,630 | 5,798 | 4,040 | 5,966 |
| Operating Expenses | 18,519 | 18,660 | 18,932 | 18,764 | 15,965 |
| Operating Income | -10,745 | -13,030 | -13,134 | -14,724 | -9,999 |
| Interest Expense | 43 | 27 | 32 | 41 | 48 |
| Other Income | -2,349 | 766 | 3,407 | 2,124 | -3,303 |
| Pre-tax Income | -13,137 | -12,291 | -9,759 | -12,641 | -13,350 |
| Net Income Continuous | -13,137 | -8,662 | -9,759 | -12,641 | -13,350 |
| Net Income | $-13,137 | $-8,662 | $-9,759 | $-12,641 | $-13,350 |
| EPS Basic Total Ops | -0.35 | -0.24 | -0.28 | -0.37 | -0.39 |
| EPS Basic Continuous Ops | -0.35 | -0.25 | -0.28 | -0.37 | -0.39 |
| EPS Diluted Total Ops | -0.35 | -0.24 | -0.28 | -0.37 | -0.39 |
| EPS Diluted Continuous Ops | -0.35 | -0.25 | -0.28 | -0.37 | -0.39 |
| EBITDA(a) | $-10,325 | $-12,688 | $-12,755 | $-14,298 | $-9,561 |